Evaluation of Aqueous Extract from Cosmos caudatus Leaves in Alloxan-Induced Diabetic Rats
Abstract
Kenikir (Cosmos caudatus), often consumed as a vegetable in Southeast Asia, possesses therapeutic benefits for several diseases, including diabetes mellitus. However, there has been limited investigation of the aqueous extract of C. caudatus for this disease model. This study aimed to examine the glucose-lowering effect of C. caudatus aqueous extract in an alloxan-induced diabetes model in rats. Ultrasound-assisted extraction was performed to obtain an aqueous extract of C. caudatus leaves. Qualitative phytochemical screening was carried out to identify the presence of bioactive compounds. Male Wistar rats were allocated to the following experimental groups: non-diabetic, diabetic without treatment, and diabetic treated with glibenclamide or aqueous C. caudatus extract at concentrations of 25%, 50%, or 100%. Diabetes was induced by intraperitoneal injection of 150 mg/kg alloxan. Random blood glucose and body weight were monitored before (Day 0) and after treatment (Days 3 and 7). There was a trend of weight loss in diabetic rats compared to non-diabetic rats, though the difference was not statistically significant. After 7 days of treatment, there was a comparable decrease in the blood glucose of diabetic rats treated with 50% or 100% of aqueous C. caudatus extract and those treated with glibenclamide. Qualitative phytochemical screening indicated the presence of steroid, saponin, phenol, and flavonoid compounds. The total phenolic content was 38.48 mg GAE/g and IC50 DPPH antioxidant activity was 375 ppm. This study demonstrated that an aqueous extract of C. caudatus exhibits a blood glucose-lowering effect in an alloxan-induced diabetic rat model.
Full text article
References
Authors
Copyright (c) 2025 Ayeshah Augusta Rosdah, Amanda Natasha, Nia Savitri Tamzil, Subandrate Subandrate

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors continue to retain the copyright to the article if the article is published in the Borneo Journal of Pharmacy. They will also retain the publishing rights to the article without any restrictions.
Authors who publish in this journal agree to the following terms:
- Any article on the copyright is retained by the author(s).
- The author grants the journal the right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share work with an acknowledgment of the work authors and initial publications in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of published articles (e.g., post-institutional repository) or publish them in a book, with acknowledgment of their initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their websites) prior to and during the submission process. This can lead to productive exchanges and earlier and greater citations of published work.
- The article and any associated published material are distributed under the Creative Commons Attribution-ShareAlike 4.0 International License.